Join
Live feed
·
INSIDERFilingvia Quantisnow
NeoGenomics Inc. logo

Director Kenny John P. converted options into 5,893 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NEO· NeoGenomics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NEO (NeoGenomics Inc.) and more on Quantisnow.